Artificial Intelligence and Deep Learning for Rheumatologists.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published Date:

Abstract

Deep learning has emerged as the leading method in machine learning, spawning a rapidly growing field of academic research and commercial applications across medicine. Deep learning could have particular relevance to rheumatology if correctly utilized. The greatest benefits of deep learning methods are seen with unstructured data frequently found in rheumatology, such as images and text, where traditional machine learning methods have struggled to unlock the trove of information held within these data formats. The basis for this success comes from the ability of deep learning to learn the structure of the underlying data. It is no surprise that the first areas of medicine that have started to experience impact from deep learning heavily rely on interpreting visual data, such as triaging radiology workflows and computer-assisted colonoscopy. Applications in rheumatology are beginning to emerge, with recent successes in areas as diverse as detecting joint erosions on plain radiography, predicting future rheumatoid arthritis disease activity, and identifying halo sign on temporal artery ultrasound. Given the important role deep learning methods are likely to play in the future of rheumatology, it is imperative that rheumatologists understand the methods and assumptions that underlie the deep learning algorithms in widespread use today, their limitations and the landscape of deep learning research that will inform algorithm development, and clinical decision support tools of the future. The best applications of deep learning in rheumatology must be informed by the clinical experience of rheumatologists, so that algorithms can be developed to tackle the most relevant clinical problems.

Authors

  • Christopher McMaster
    Department of Clinical Pharmacology, Austin Health, Level 5, Lance Townsend Building, Studley Rd, Heidelberg, VIC, 3084, Australia. christopher.mcmaster@austin.org.au.
  • Alix Bird
    Australian Institute for Machine Learning, University of Adelaide, Adelaide, South Australia, Australia.
  • David F L Liew
    Department of Rheumatology and Department of Clinical Pharmacology and Therapeutics, Austin Health, Department of Clinical Pharmacology and Therapeutics, Austin Health, and Department of Medicine, University of Melbourne, Victoria, Melbourne, Australia.
  • Russell R Buchanan
    Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Victoria, Melbourne, Australia.
  • Claire E Owen
    Department of Rheumatology, Austin Health, and Department of Medicine, University of Melbourne, Victoria, Melbourne, Australia.
  • Wendy W Chapman
    School of Medicine, University of Utah, Salt Lake City, Utah, US.
  • Douglas E V Pires
    Department of Biochemistry and Molecular Biology, University of Melbourne, Melbourne, Australia.